Marimed (MRMD) Long-Term Deferred Tax (2018 - 2020)

Marimed (MRMD) has reported Long-Term Deferred Tax for 3 consecutive years, with $57.9 million the latest figure, recorded in Q4 2020.

• On a quarterly basis, Long-Term Deferred Tax fell 16.02% year-over-year to $57.9 million in Q4 2020; TTM through Dec 2020 was $57.9 million, a 16.02% decrease from a year earlier, with the FY2020 full-year figure at $57.9 million, down 16.02% from the prior year.
• Long-Term Deferred Tax was $57.9 million for Q4 2020 at Marimed, down from $68.9 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $68.9 million in Q4 2019 and troughed at $11.6 million in Q4 2018.
• A 3-year average of $46.1 million and a median of $57.9 million in 2020 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax surged 495.93% in 2019 and retreated 16.02% in 2020, its largest moves.
• Over 3 years, Long-Term Deferred Tax stood at $11.6 million in 2018, then surged by 495.93% to $68.9 million in 2019, then slipped by 16.02% to $57.9 million in 2020.
• The last three Long-Term Deferred Tax figures came in at $57.9 million (Q4 2020), $68.9 million (Q4 2019), and $11.6 million (Q4 2018), per Business Quant data.